CAI and phData Forge Strategic Partnership to Accelerate AI-Driven Operational Readiness in Life Sciences
Indianapolis, IN — July 3, 2025 — CAI, a global professional services firm renowned for Operational Readiness and Operational Excellence, today announced a strategic partnership...
Read MoreCAI and ValGenesis Partner to Deliver AI-Enabled Digital Validation for the Life Sciences Industry
INDIANAPOLIS, Ind. — July 1, 2025 — CAI, a global professional services firm specializing in operational readiness for regulated industries, today announced a strategic partnership...
Read MoreIslands of Automation Are No Vacation
In highly regulated industries, “Islands of Automation” might sound like streamlined, independent systems working in harmony. But the reality is far from ideal. These disconnected...
Read MoreBuilding the Future of Pharmaceutical Manufacturing: A Phased Approach to Dark Factories
Why Invest in a Dark Factory? Pharmaceutical manufacturers are under increasing pressure to meet growing patient demand, accelerate drug development timelines, and adapt to evolving...
Read MorePioneering Progress: How Innovation is Transforming Manufacturing Operations
Manufacturing has entered a new era in which success depends on more than traditional optimization methods. While Lean and Six Sigma have served as foundational...
Read MoreDriving Operational Excellence: Leveraging Technology for Industry-Wide Innovation
Introduction: The Next Evolution of Operational Excellence Operational Excellence (OE) has long been the foundation of high-performing industries, ensuring efficiency, reliability, and quality in Life...
Read MoreEngaging Early: FDA’s Collaborative Pathways for AI in Regulatory Applications (Part 3 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read MoreSustaining Reliability: Life Cycle Maintenance of AI Models in Drug Development (Part 2 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read MoreA Framework for Trust: Understanding the FDA’s AI Risk-Based Credibility Assessment (Part 1 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read More